Their Current Valuation Deserve Consideration: TG Therapeutics, Inc. (TGTX), Activision Blizzard, Inc. (ATVI) – Post Analyst

This post was originally published on this site

Their Current Valuation Deserve Consideration: TG Therapeutics, Inc. (TGTX), Activision Blizzard, Inc. (ATVI)  Post Analyst

Here’s what’s interesting to note about TG Therapeutics, Inc. (NASDAQ:TGTX) right now: Its price-to-sales ratio of 4302.73, is expensive relative to the …

This post was originally published on *this site*